Anti-IL-17A treatment reduces clinical score and VCAM-1 expression detected by in vivo magnetic resonance imaging in chronic relapsing EAE ABH mice
about
Molecular magnetic resonance imaging of brain-immune interactionsIntracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathwayInterleukin 17A Promotes Lymphocytes Adhesion and Induces CCL2 and CXCL1 Release from Brain Endothelial Cells.Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis.The role of IL-17 in CNS diseases.Editorial: Ontogeny and Phylogeny of Brain Barrier Mechanisms.Prediction of disease activity in models of multiple sclerosis by molecular magnetic resonance imaging of P-selectin.Alterations in serum levels of IL-17 in contrast to TNF-alpha correspond to disease-modifying treatment in relapsing-remitting multiple sclerosis.NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis.Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis.Monoclonal Antibodies in Preclinical EAE Models of Multiple Sclerosis: A Systematic Review.Molecular Magnetic Resonance Imaging of Endothelial Activation in the Central Nervous System.IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis.
P2860
Q21129471-F7847808-819B-4235-8A92-018F42FFFBB1Q30724821-724967CF-376F-481C-8FDF-2B6A03DAF38BQ33755098-1B48A25E-355D-43D3-97B4-F727ADB0FC53Q37019872-9164E614-DACF-4CA7-9561-2E249A9E0599Q38365272-7BC91AEF-A080-4B0B-BE52-B5BD09EC3017Q38467081-AC8059B8-7115-476F-99B9-C71A621CE610Q38680497-F3425F64-E161-42EE-8544-60CB5845F15BQ38893637-E2ECBAF9-ADA6-41FF-990D-7DA982651273Q38987058-3EF56719-DCFE-450A-9F17-860556F10549Q39119839-81AB1811-84A9-4FD9-815C-CD904E385ED4Q41660408-AE7D9ED6-E0AF-43B0-9AA0-B950DEE08DF0Q51765579-1989BB27-0FE0-4D5D-9115-2DC8C0CCDD32Q55071045-997F0102-B2E7-473E-8743-EDE5A232B5D0
P2860
Anti-IL-17A treatment reduces clinical score and VCAM-1 expression detected by in vivo magnetic resonance imaging in chronic relapsing EAE ABH mice
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Anti-IL-17A treatment reduces ...... chronic relapsing EAE ABH mice
@en
type
label
Anti-IL-17A treatment reduces ...... chronic relapsing EAE ABH mice
@en
prefLabel
Anti-IL-17A treatment reduces ...... chronic relapsing EAE ABH mice
@en
P2093
P2860
P1476
Anti-IL-17A treatment reduces ...... chronic relapsing EAE ABH mice
@en
P2093
Charles McFadyen
Emma Ladds
Fay Saunders
Gillian Watt
Martina McAteer
Nicola R Sibson
Panop Wilainam
Paul Smith
Robin P Choudhury
Sandra J Campbell
P2860
P304
P356
10.1016/J.AJPATH.2013.02.029
P407
P577
2013-04-16T00:00:00Z